Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospital Civil de Guadalajara
Despite ongoing trials of antivirals and immunomodulatory therapies against COVID-19, the treatment of moderate/severe disease is mainly supportive, including oxygen therapy and invasive mechanical ventilation when impending respiratory failure is established. Moreover, the associated mortality among mechanically intubated patients is overwhelmingly high. Prone position relieves the dependent lung regions from the compressive forces of the mediastinum's weight, leading to homogenization of the gas:tissue ratio between ventral and dorsal lung regions. According to a few case series, and observational non-randomized studies with small sample sizes, there is a consistent improvement in oxygenation in COVID-19 patients during prone positioning, however there are no clinical evidence that this improvement is associated with a decrease in the risk of invasive mechanical ventilation. Considering that prone positioning is a low cost, low risk and widely available therapy, more high quality evidence is needed, to determine if the benefits of prone positioning in awake patients also include a lower requirement of mechanical ventilation.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients with confirmed COVID-19, and requirement of a fraction of inspired oxygen (FiO2) ≥30% through high-flow nasal cannula (HFNC) to maintain a capillary saturation of ≥90%
You may not be if
Less than 18 years-old
Pregnancy
Patients with immediate need of invasive mechanical ventilation
Contraindications for prone positioning therapy
Do-not-resuscitate or do-not-intubate order
Refusal of the patient or decision maker to enroll in the study